Bard Buys Genyx For Urethral Bulking Agent Following FDA Sign-Off
This article was originally published in The Gray Sheet
Executive Summary
Bard's $60 mil. purchase of Genyx Medical comes less than a month after PMA approval of Genyx's Uryx injectable bulking agent for stress urinary incontinence